Cite
MLA Citation
Adi Diab et al.. “420 Progression-free survival and biomarker correlates of response with BEMPEG plus NIVO in previously untreated patients with metastatic melanoma: results from the PIVOT-02 study.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A446. http://access.bl.uk/ark:/81055/vdc_100144716836.0x000007